Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection
Condition(s):Clostridium DifficileLast Updated:December 13, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Clostridium DifficileLast Updated:December 13, 2022Terminated
Condition(s):Fecal Microbiota Transplantation; Cesarean Section; Overweight and ObesityLast Updated:February 28, 2024Not yet recruiting
Condition(s):Enterobacteriaceae Infections; Fecal Microbiota TransplantationLast Updated:October 23, 2019Withdrawn
Condition(s):Acute Graft-Versus-Host Disease (Gvhd) Grade; Hematopoietic Cell Transplantation; Fecal Microbiota TransplantLast Updated:March 7, 2024Completed
Condition(s):Recurrent Urinary Tract InfectionLast Updated:June 18, 2020Completed
Condition(s):Auto-Brewery Syndrome; Gut Fermentation SyndromeLast Updated:March 12, 2024Not yet recruiting
Condition(s):Ulcerative ColitisLast Updated:June 14, 2016Completed
Condition(s):Intestinal Pseudo-Obstruction; Fecal Microbiota TransplantationLast Updated:August 31, 2023Completed
Condition(s):Alzheimer DiseaseLast Updated:July 24, 2020Terminated
Condition(s):Clostridium Difficile InfectionLast Updated:December 15, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.